admin_zika_website, Author at Zika - Page 11 of 14

All fields are required.

Close Appointment form

Archive for

  • Author Archive
  • icon
    Structural investigation of C6/36 and Vero cell cultures infected with a Brazilian Zika virus

    By Barreto-Vieira DF, Jacome FC, da Silva MAN, et al.

    Zika virus (ZIKV) is a member of the flavivirus genus, and its genome is approximately 10.8 kilobases of positive-strand RNA enclosed in a capsid and surrounded by a membrane. Studies on the replication dynamics of ZIKV are scarce, which limits the development of antiviral agents and vaccines directed against ZIKV. In this study, Aedes albopictus mosquito lineage cells (C6/36 cells) and African green monkey kidney epithelial cells (Vero cells) were inoculated with a ZIKV sample isolated from a Brazilian patient, and the infection was characterized by immunofluorescence staining, phase contrast light microscopy, transmission electron microscopy and real-time RT-PCR. The infection was observed in both cell lineages, and ZIKV particles were observed inside lysosomes, the rough endoplasmic reticulum and viroplasm-like structures. The susceptibility of C6/36 and Vero cells to ZIKV infection was demonstrated. Moreover, this study showed that part of the replicative cycle may occur within viroplasm-like structures, which has not been previously demonstrated in other flaviviruses.

    Published in: PLoS One2017;12(9):e0184397.

    Read the publication
    icon
    Zika genomics urgently need standardized and curated reference sequences

    By Theys K, Libin P, Dallmeier K, et al.

    In this letter, the authors address the need for curation and standardized annotation of ZIKV reference genomes in order to guide researchers and clinicians in genomic analyses and the translation of research findings.

    Published in: PLoS Pathog. 2017;13(9):e1006528

     

    Read the publication
    icon
    Diagnostics for the vertical transmission and paediatric studies. An article by Eleni Nastouli

    The main focus of our group has been the optimisation of the current algorithm for testing pregnant women and their infants recruited in the ZIKAction studies. We started recruitment in Jamaica which is exciting and in order to answer the questions around vertical transmission in symptomatic and asymptomatic women at a given site and at a given time we were faced with challenging dilemmas around the optimal sampling protocol and importantly the optimal testing strategy for arbovirus infections (Zika, dengue and chikungunya).

    View post
    icon
    Antibody-based assay discriminates Zika virus infection from other flaviviruses

    By Balmaseda A, Stettler K, Medialdea-Carrera R, Collado D, Jin X, Zambrana JV, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira PBrown DWG, Baldanti F, Tedder R, Zambon M, de Filippis AMB, Harris E, Corti D.

    Zika virus (ZIKV) is a mosquito-borne flavivirus that emerged recently as a global health threat, causing a pandemic in the Americas. ZIKV infection mostly causes mild disease, but is linked to devastating congenital birth defects and Guillain-Barré syndrome in adults. The high level of cross-reactivity among flaviviruses and their cocirculation has complicated serological approaches to differentially detect ZIKV and dengue virus (DENV) infections, accentuating the urgent need for a specific and sensitive serological test.

    Published in: Proc Natl Acad Sci U S A. 2017Aug 1;114(31):8384-8389.

    Read the publication